Meningococcal disease - Epidemiological and clinical features;Meningokokna bolest - Epidemiološke i kliničke značajke

Paediatria Croatica, Supplement

Volumn 55, Issue SUPPL. 1, 2011, Pages 98-105

  Čeljuska Tošev, Elvira ^a   Bukovski Simonoski, Suzana ^b   Gužvinec, Marija ^b   Kovačević, Gorana ^b   Knezović, Ivica ^a  

^a Croatia   (Croatia)

^b NONE

Author keywords

Bacterial meningitis; Invasive meningococcal disease; Sepsis

Indexed keywords

BACTERIAL MENINGITIS; CLINICAL FEATURE; CROATIA; HOSPITALIZATION; HUMAN; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; REVIEW; SEPSIS; TREATMENT OUTCOME;

EID: 82455192508     PISSN: 1330724X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Anderson MS, Glodé MP, Smith AL. Meningococcal Infections. U: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, ur. Feigin & Cherry's Textbook of Pediatric Infectious Diseases, 6. izd. Philadelphia: Saunders Elsevier, 2009; 1350-66.
2. Apicella M. Neisseria meningitdis. U: Mandell GL, Bennett JE, Dolin R, ur. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 6. izd. Philadelphia: Elsevier/Churchill Livingstone, 2005; 2498-513.
3. Božinović D, Boras A. Neisseria meningitidis. U: Begovac J, Božinović D, Lisić M, Baršić B, Schoenwald S, ur. Infektologija. 1. izd. Zagreb: Profil,2006;598-607.
4. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, i sur. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
5. Čeljuska-Tošev E, Bukovski-Simonoski S, Gužvinec M, Knezović I. Epidemiološke i kliničke značajke bolesnika s invazivnom meningokoknom bolešću hospitaliziranih u Klinici za infektivne bolesti "Dr. Fran Mihaljević" u Zagrebu. Infektol Glasn 2009; 29: 111-20.
6. Hrvatski zavod za javno zdravstvo. Hrvatski zdravstveno- statistički ljetopis za 2008. godinu. URL: http://www.hzjz.hr/ publikacije.htm.
7. Petrovečki M. Uzorak i populacija. U: MarušićM, ur. Uvod u znanstveni rad u medicini. 4. izd. Zagreb: Medicinska naklada, 2008; 50-9.
8. Petrovečki M. Obradba podataka. U: Marušić M, ur. Uvod u znanstveni rad u medicini. 4. izd. Zagreb: Medicinska naklada, 2008; 97-115.
9. Cuevas LE, Jeanne I, Molesworth A, Bell M, Savory EC, Connor SJ, i sur. Risk mapping and early warning systems for the control of meningitis in Africa. Vaccine 2007; 25 (1): 12-7.
10. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, i sur. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999; 180: 1894-901.
11. st century. Adv Pediatr 2005; 52: 129-62.
12. Klinika za infektivne bolesti "Dr. Fran Mihaljević", Zagreb. Izvješće o medicinskom radu - godišnja izvješća 1969.-2009.
13. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, i sur. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006; 367: 397-403. (Pubitemid 43184259)
14. American Academy of Pediatrics. Meningococcal Infections. U: Pickering LK, Baker CJ, Kimberlin DW, Long SS, ur. Red Book: 2009 Report of the Committee on Infectious Diseases. 28. izd. Elk Grove Village, IL: American Academy of Pediatrics, 2009; 455-63.
15. EU-IBIS Network. Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London 2006. URL: http://www.eui-bis.com.
16. Chandra M, Ramsay M. EU-IBIS: Surveillance and epidemiology of invasive meningococcal disease in Europe 1999-2006. URL: http://www.euibis.org/documents/ emgm-07-pdfs/euibis-surveillance-emgm07.pdf.
17. Kaplan SL, Schutze GE, Leake JA, Barson WJ, Halasa NB, Byington CL, i sur. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics 2006; 118: 979-84.
18. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 1993; 340: 1432-4.
19. th Meeting of The European Monitoring Group on Meningococci - Abstract Book. Dublin, Ireland; 2005.
20. Michael A, Stephen BC, Morven SE, Anna RT. Clinical manifestations of meningococcal infection. URL: http://www.uptodate.com.
21. Pollard AJ, Nadel S, Ninis N, Faust SN, Levin M. Emergency management of meningococcal disease: eight years on. Arch Dis Child 2007; 92 (2): 83-6.
22. Hahné SJ, Charlett A, Purcell B, Samuelsson S, Camaroni I, Ehrhard I, i sur. Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: Systematic review. BMJ 2006; 332: 1299-301. (Pubitemid 44365383)
23. Boras. A, Božinović. D, Tenover. F, Popović T. First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia. J Clin Microbiol 2001; 39: 823.
24. Tambić Andrašević A. Rezistencija na antibiotike najvažnijih bakterijskih patogena u dječjoj dobi. Pediatr Croat 2005; 49 (1): 198-201. (Pubitemid 351525231)
25. Howitz M, Lambersten L, Simonesn JB, Christensen JJ, Molbak K. Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007. Epidemiol Infect 2009; 137: 1631-40.
26. Feavers I. ABC of meningococcal diversity. Nature 2000; 404: 451-2. (Pubitemid 30186873)
27. Harrison LH. Prospects for Vaccine Prevention of Meningococcal Infection. Clin Microbiol Rev 2006; 19: 142-64. (Pubitemid 43157651)
28. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, i sur. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140-5. (Pubitemid 28135868)
29. Taha MK, Alonso JM. Molecular epidemiology of infectious diseases: the example of meningococcal disease. Res Microbiol 2008; 159: 62-6.
30. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. U: Plotkin SA, Orenstein WA, Offit P, ur. Vaccines. 5. izd. Philadelphia: Saunders Elsevier, 2008; 399-434.
31. Oster P, Lennon D, O'Hallahan J, Mulholland K, Reid S, Martin D. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 2005; 23: 2191-6. (Pubitemid 40341449)
32. Oster P, O'Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand. Vaccine 2007; 25: 3075-9. (Pubitemid 46482737)
33. Girard MP, Preziosi MP, Aguado MT, Kieny MP. A review of vaccine research and development: meningococcal disease. Vaccine 2006; 24: 4692-700. (Pubitemid 43776790)
34. Perrett KP, Pollard AJ. Towards an improved serogroup B Neisseria meningitidis vaccine. Expert Opin Biol Ther 2005; 5: 1611-25. (Pubitemid 41771852)